Heart Failure and Cardiomyopathies

My Settings
Relevant Content
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Graded Associations Between Left Ventricular Ejection Fraction Improvement and Cardiorenal Outcomes in Heart Failure With Improved Ejection Fraction
Journal of the American Heart Association, Ahead of Print.
Background...
Clinical Course and Predictors of Heart Failure in Asymptomatic Obstructive Hypertrophic Cardiomyopathy
Journal of the American Heart Association, Ahead of Print.
Background...
Stanniocalcin‐1 Attenuates Cardiac Fibrosis Post Ischemia–Reperfusion Injury by Targeting the DOCKER Domain of Dedicator of Cytokinesis 1
Journal of the American Heart Association, Ahead of Print.
Background...
Prognostic Value of the Meta‐Analysis Global Group in Chronic Heart Failure Risk Score in Patients Undergoing Mitral Valve Transcatheter Edge‐to‐Edge Repair
Journal of the American Heart Association, Ahead of Print.
Background...
Neighborhood‐Level Socially Determined Vulnerabilities and Outcomes After Heart Failure Hospitalization
Journal of the American Heart Association, Ahead of Print.
Background...
Metabolic Task Analysis Reveals Distinct Metabotypes in End-Stage Dilated Cardiomyopathy
Circulation: Genomic and Precision Medicine, Ahead of Print.
BACKGROU...
Unlocking the Regulatory Genome: Interpreting the Clinical Impact of Noncoding Variants in Genetic Cardiomyopathies
Circulation: Genomic and Precision Medicine, Ahead of Print.
Clinical...
Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy
Circulation: Heart Failure, Ahead of Print.
BACKGROUND:Acoramidis ach...
SBK2 Links Cardiac Stress Signaling to Mitochondrial Proteostasis
Circulation Research, Volume 139, Issue 2, Page e328983, July 6, 2026.